10-month-old baby boy becomes first in Hong Kong to receive life-extending gene therapy treatment for rare neuromuscular disorder

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

The Hospital Authority has introduced a single injection of a new drug called ‘Zolgensma’ for Spinal Muscular Atrophy (SMA) patients.